Kenneth Ndugga-Kabuye, M.D., FACMG

Dr. Ken Ndugga-Kabuye is Vice President, Cell & Gene Therapy at Premier Research. He brings direct experience supporting drug development candidates for clinical studies leveraging innovative approaches in the treatment of disease, inclusive of cell and gene therapies, synthetic biotics, RNA therapies, and enzyme replacement therapies.

In previous roles, Dr. Ndugga-Kabuye has supported CRO and biotechnology clients in the ATMP space. Dr. Ndugga-Kabuye is a clinical geneticist with residency and fellowship training in medical genetics and genomics from the University of Washington in Seattle, WA, US. He is board certified by the American Board of Medical Genetics and Genomics in Clinical Genetics and Genomics. He holds a medical license in Washington State and California. He is a Diplomate of the American Board of Medical Genetics and Genomics. He is a member of the American Society of Human Genetics (ASHG), the European Society of Human Genetics (ESHG), the American College of Medical Genetics (ACMG), the African Society of Human Genetics (AfSHG), the American Medical Association (AMA) and the American Academy of Pediatrics (AAP).